Filing Details
- Accession Number:
- 0001179110-16-025648
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-27 17:26:51
- Reporting Period:
- 2016-05-26
- Filing Date:
- 2016-05-27
- Accepted Time:
- 2016-05-27 17:26:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061027 | Sunesis Pharmaceuticals Inc | SNSS | Pharmaceutical Preparations (2834) | 943295878 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491874 | M. Geoffrey Parker | 395 Oyster Point Blvd. Suite 400 San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-05-26 | 9,500 | $0.47 | 62,005 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.4634 to $0.4762, inclusive. The reporting person undertakes to provide Sunesis Pharmaceuticals, Inc., any security holder of Sunesis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote(1)to this Form 4.
Billionaire Hedge Funds
